Natalie Staplin

PhD

MRC PHRU Senior Statistician

Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Sciences. She joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics. Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease. She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.

Recent publications

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article

LANDRAY M. et al, (2021), The Lancet
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article

The RECOVERY Collaborative Group None. et al, (2021)
Dexamethasone in Hospitalized Patients with Covid-19.
Journal article

RECOVERY Collaborative Group None. et al, (2021), N Engl J Med, 384, 693 - 704
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article

RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Journal article

RECOVERY Collaborative Group None. et al, (2021)